Extramedullary T lymphoblastic transformation of chronic myeloid leukaemia occurring after double allogeneic transplantation

Bone Marrow Transplantation

Volumn 22, Issue 8, 1998, Pages 813-816

  Kell, J ^a   Booth, M ^a   Jones, B ^a   Appleton, M ^a   Lim, S ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Allogeneic bone marrow transplantation; Chronic myeloid leukaemia; Donor lymphocyte infusion; Interleukin 2; T lymphoblastic transformation

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MALE; PRIORITY JOURNAL; T LYMPHOBLAST;

EID: 0031769541     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701430     Document Type: Article

References (22)

1. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-293.
2. Griffin JD, Todd RF, Ritz J et al. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983; 61: 85-91.
3. Kantarjian HM, Keating MJ, Talpaz M et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 1987; 83: 445-454.
4. Specchia G, Palumbo G, Pastore D et al. Extramedullary blast crisis in chronic myeloid leukemia. Leukemia Res 1996; 20: 905-908.
5. Jacknow G, Frizzera G, Gajl-Peczalska K et al. Extramedullary presentation of the blast crisis of chronic myelogenous leukaemia. Br J Haematol 1985; 61: 225-236.
6. Gonzalez FA, Villegas A, Ferro MT et al. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia. Br J Haematol 1993; 84: 351-352.
7. Jacob A, Rowlands DC, Patton N, Holmes JA. Chronic granulocytic leukaemia presenting with an extramedullary T lymphoblastic crisis. Br J Haematol 1994; 88: 435-436.
8. Jacobs P, Greaves M. Ph1-positive T lymphoblastic transformation. Leukemia Res 1984; 8: 737-739.
9. Yasukawa M, Iwamasa K, Kawamura S et al. Phenotypic and genotypic analysis of chronic myelogenous leukaemia with T lymphoblastic and megakaryoblastic mixed crisis. Br J Haematol 1987; 66: 331-336.
10. Palutke M, Eisenberg L, Nathan L. Phi-positive T lymphoblastic transformation of chronic granulocytic leukemia in a lymph node (letter). Lancet 1982; 2: 1053.
11. Fauser AA, Kanz L, Bross KJ, Lohr GW, T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia. J Clin Invest 1985; 75: 1080-1082.
12. Dorfman DM, Longtine JA, Fox EA et al. T-cell blast crisis in chronic rnyelogenous leukemia. Immunophenotypic and molecular biologic findings. Am J Clin Paihol 1997; 107: 168-176.
13. Bacigalupo A, Soracco M, Vassallo F et al. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic hone marrow transplantation. Bone Marrow Transplant 1997; 19: 927-932.
14. Mehta J, Powles R, Kulkarni S et al. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients. Bone Marrow Transplant 1997; 20: 129-135.
15. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041-2050.
16. Atra A, Millar B, Shepherd V et al. Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation. Br J Haematol 1997; 97: 165-168.
17. Glass B, Majolino I, Dreger P et al. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 533-541.
18. Tringali S, Vasta S, Seime R et al. Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion. Haematologica 1996; 81: 339-342.
19. Salutari P, Sica S, Micciulli G et al. Extramedullary relapse after allogeneic bone marrow transplantation plus buffy-coat -in two high risk patients, Haematologica 1996; 81: 182-185.
20. Slavin S, Naparstek E, Nagler A et al Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.
21. Giralt S, Hester J, Huh Y et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 1995; 86: 4337-4343.
22. Champlin R. Separation of graft-vs-host disease and graft-vs-leukemia effect against chronic myelogenous leukemia. Exp Hematol 1995; 23: 1148-1151.